Chairmen Guthrie and Griffith Announce Health Subcommittee Markup of 15 Bills Addressing Illicit Drugs and Health Care Price Transparency

WASHINGTON, D.C. – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, and Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Health, announced a subcommittee markup of bills to safeguard Americans from illicit substances and increase price transparency in our health care system.

WHAT: Subcommittee on Health markup on legislation to bring real price transparency to patients and employers across the nation, as well as legislation to safeguard communities from the threat of illicit substances.

DATE: Thursday, June 25, 2026

TIME: 2:00 PM ET

LOCATION: 2123 Rayburn House Office Building

Items to be considered:

• H.R. 1266, Combatting Illicit Xylazine Act (Reps. Panetta and Pfluger)
• H.R. 2004, Tyler’s Law (Reps. Lieu and Latta)
• H.R. 7970, STOP Nitazenes Act (Rep. Latta)
• H.R. 1561, ALERT Communities Act (Reps. Crockett and Gooden)
• H.R. 7994, HERO Act (Rep. Ruiz)
• H.R. 9389, Nutrition Education and Chronic Disease Prevention in Community Health Centers Act of 2026 (Rep. Harshbarger)
• H.R. 8201, Expanding Community Access to Health Services Act (Rep. Lee (NV))
• H.R. 9393, Lower Costs, More Transparency Act of 2026 (Reps. Guthrie and Pallone)
• H.R. 9397, Premium Transparency Act (Reps. Pfluger and Moran)
• H.R. 9396, Prior Authorization Accountability Act (Rep. Goldman (TX))
• H.R. 9390, Prices on the Wall Act of 2026 (Rep. Miller-Meeks)
• H.R. 3514, Improving Seniors’ Timely Access to Care Act of 2025 (Reps. Kelly and DelBene)
• H.R. 9392, Medicare Advantage Cost Transparency Act (Reps. DeGette and Joyce (PA))
• H.R. 5243, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage. (Rep. McClellan)
• H.R. 9395, Transparency in Medicare Advantage Steering Act (Rep. Ocasio-Cortez)